化对骨Pb储存的作用,在Pb中毒的儿童中
Aaron J Specht1,2, Yanfen Lin3, Jian Xu3
1School of Health Sciences, Purdue University, West Lafayette, IN, USA. aspecht@purdue.edu.
Journal of exposure science & environmental epidemiology
|December 3, 2024
概括
化疗显著降低了中毒儿童的骨含量. 这种治疗减轻了身体的能量.
科学领域:
- 儿科 环境卫生 儿童 环境卫生
- 毒理学 毒理学 毒理学
- 化疗法是一种治疗方法.
背景情况:
- 儿童暴露是一个持续的公共卫生问题,具有长期的发展后果.
- 骨占儿童体内总负荷的很大一部分 (60-90%),作为内源性释放的储.
- 化疗对中毒的疗效仍然是正在进行的研究和辩论的主题.
研究的目的:
- 评估化疗对被诊断患有中毒的儿童骨头水平的影响.
- 为了量化静脉输入乙烯基胺酸 (EDTA) 治疗后骨储量的变化.
主要方法:
- 在中国上海新华医院被诊断患有中毒 (血>25μg/dL) 的儿童被纳入.
- 参与者接受了为期一周的静脉EDTA化疗程,在治疗前后测量骨度.
- 在为期两年的研究期间,骨测量和治疗方案重复多达三次.
主要成果:
- 在切拉治疗后观察到骨含量有统计学意义的减少 (p < 0.0001).
- 即使考虑了理论骨周转率 (p = 0.01),这种减少仍然很大.
- 随着重复的化治疗,骨减少的幅度增加.
结论:
- 化疗是一种有效的干预措施,用于减少血中含量升高 (>25μg/dL) 的儿童的骨储量.
- 通过化来减少骨的负担,可以减轻长期内源性暴露和相关健康影响的风险.
- 这项研究支持结合疗法作为一种可行的策略,用于管理儿科患者中中毒.
相关概念视频
Extraction: Advanced Methods
415
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
415
Complexation Equilibria: The Chelate Effect
444
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
444
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Masking and Demasking Agents
2.3K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.3K


